The aim of this collaboration is to develop an EU/EEA-wide system for the exchange of existing and new scientific evidence and the joint generation of up-to-date scientific evidence, if possible in systematic literature reviews using evidence-based methodology, on public health outcomes on vaccines authorised in the EU and their use in immunisation programmes.
This e-learning course is designed to take approximately 2 hours to complete. It is non-moderated and self-paced course. You can decide when to start it, interrupt and resume to continue at any time.
ECDC infographics on measles: Measles affects all age groups, Measles is a serious disease, Measles is more contagious than you think, Measles in Europe - a picture of outbreaks in the EU/EEA.
As of 2 March 2020, ECDC no longer defines areas of presumed community transmission. Please refer to WHO situation reports for country classification [hyperlink: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/
Find ECDC resources on preparedness and prevention and control measures of COVID-19, such as guidance and technical reports for patient and case management, personal protective equipment, preventive measures.